Aztreonam vs. cefotaxime in the treatment of gram‐negative spontaneous peritonitis in cirrhotic patients
Javier Ariza, Xavier Xiol, Maria Esteve, Fernando Fernández Bañeres, Josefina Liñares, Teresa Alonso, Francisco Gudiol – 1 July 1991 – Aztreonam and cefotaxime were compared in 44 cirrhotic patients who had 52 episodes of gramnegative spontaneous peritonitis. Patients were randomized into two therapeutic groups of similar characteristics. Group A (28 episodes) received 0.5 gm of aztreonam every 8 hr, and group B (24 episodes) received 1 gm of cefotaxime every 6 hr, for a planned 14‐day period.